Amgen's marketing efforts help boost Tepezza sales
Fierce Pharma
AUGUST 7, 2024
In the second quarter, Tepezza generated $479 million in sales for an increase of 8% year over year and 13% sequentially. It was Tepezza’s highest quarterly sales figure since Q4 of 2022. Is the thyroid eye disease (TED) treatment finally gaining momentum that is sustainable?
Let's personalize your content